<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55284">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01842932</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-CT4-09-257</org_study_id>
    <nct_id>NCT01842932</nct_id>
  </id_info>
  <brief_title>Usefulness Of Flospan As A Premedication For Colonoscopy</brief_title>
  <official_title>Usefulness Of Flospan As A Premedication For Colonoscopy : A Randomized Double Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Usefulness of Flospan as a premedication for colonoscopy: A randomized double-blind
      controlled trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cimetropium bromide is premedication of colonoscopy. However, it is contraindication for
      some diseases; benign prostatic hyperplasia(BPH) or other obstructive uropathy, intestinal
      obstruction, pyloric stenosis, glaucoma, myasthenia gravis, megacolon, paralytic ileus. In
      this cases, Flospan (phloroglucin) is effective alternative drug. So our research was to
      compare the effects of these two drugs.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Non inferiority of phloroglucin to cimetropium bromide</measure>
    <time_frame>Up to ten months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparing the two groups of time of examination, frequency of peristalsis, Scoring for the experimenter and the subject of the inspection feedback, double-blind setting.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total diagnostic colonoscopy exam time</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of practitioners</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Colonic motility and test difficulty</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of subjects</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The degree of discomfort after test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peristalsis time of transverse colon</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total peristalsis time of transverse colon for two minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose and times of sedatives for pain control</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total dose and times of sedatives (midazolam, propofol) for pain control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of cecal intubation</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total time of colonoscope intubation from anus to cecum</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Bowel cleansing status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Heart rate, respiratory rate, oxygen saturation, blood pressure</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phloroglucin 20ml before examination &amp; Placebo 1ml before examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cimetropium bromide 1ml before examination &amp; Placebo 20ml before examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phloroglucin</intervention_name>
    <description>Premedication of colonoscopy</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <other_name>Flospan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cimetropium bromide</intervention_name>
    <description>Premedication of colonoscopy</description>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <other_name>Anticholinergics</other_name>
    <other_name>Algiron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Diagnostic examination of colon</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <other_name>Diagnostic examination of colon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for double-blind study These are harmless to the human body, and are composed of saline solution without drug efficacy.</description>
    <arm_group_label>Phloroglucin &amp; Placebo</arm_group_label>
    <arm_group_label>Cimetropium bromide &amp; Placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipient endoscopic diagnostic purposes.

        Exclusion Criteria:

          -  If you currently pregnant, or of childbearing potential

          -  Previous abdominal surgery or bowel resection.

          -  If under 18 years of age

          -  If the last two days, the administration of anticholinergic
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kee Myung Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <zip>443-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 26, 2013</lastchanged_date>
  <firstreceived_date>April 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Sun Gyo Lim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Anticholinergics</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>DA 3177</mesh_term>
    <mesh_term>Cholinergic Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
